LongeVC Fund II, LP
RaisingEmerging manager
Raising: Form D filed Nov 2025 reports an open-ended (indefinite) offering
- Vintage
- 2025
- Fund size
- $11.5M (Form D)
- Stages
- Not stated
- Sectors
- Not stated
- Regions
- Not stated
01 · Thesis
LongeVC Fund II, LP is the fund under which the portfolio page groups Trogenix, which develops precision cancer treatments that selectively target diseased cell states and behavior. The page gives no further details about this fund.
02 · Initial check
$115K to $192K (estimated from fund size)
Estimated from Form D
03 · Who to approach
Named on this fund's Form D
- William Usdin, Manager of the General Partner of the Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
The portfolio page groups Trogenix under Fund II. The page gives no further fund details.
fund II Precision therapies engineered for change
https://longevc.com/portfolio
06 · Sources
Last verified: Oct 25, 2026